The BMJ Awards 2019: UK Research Paper of the YearBMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l1866 (Published 24 April 2019) Cite this as: BMJ 2019;365:l1866
- Jacqui Wise, freelance journalist
- London, UK
For the past 25 years, men with suspected prostate cancer on the basis of a raised prostate specific antigen (PSA) test have typically been offered standard transrectal ultrasonography (TRUS) guided biopsy of the prostate gland. However, this approach sometimes misses clinically significant tumours and can lead to the over-detection of low grade cancers.
The PRECISION trial1 was one of the first multicentre …